Your location：Home > Pharmaceutical >17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-
17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-
Basic Information
- CAS No.: 125-66-6
Physical properties
Product Description
Quality products?make an important contribution to long-term revenue and profitability. Manufacturer supply good quality 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- 125-66-6 with stock
1.What is the 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- ?
Since the provided materials do not specify the uses of 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-, I can only infer potential applications based on its classification and properties. Here are some hypothetical uses:
Used in Pharmaceutical Industry:
17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)could be used as a pharmaceutical agent for its potential anti-inflammatory properties, helping to reduce inflammation in various conditions.
Used in Oncology:
In the field of oncology, 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- might be utilized as an anti-cancer agent, potentially targeting various types of cancer due to its ability to interfere with cancer cell growth and proliferation.
Used in Diabetes Management:
For diabetes management, 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)could be employed as an anti-diabetic agent, possibly aiding in the regulation of blood sugar levels and improving insulin sensitivity.
-
-
110-17-8,26099-09-2
(2E)-but-2-enedioic acid
-
-
125-66-6
fumaropimaric acid
| Conditions | Yield |
|---|---|
|
With
rosin;
at 220 ℃;
for 3h;
Inert atmosphere;
|
-
-
79-54-9
levopimaric acid
-
-
125-66-6
fumaropimaric acid
| Conditions | Yield |
|---|---|
|
Multi-step reaction
with
2
steps
1: 200 °C
2: potassium hydroxide / methanol / 2 h / Reflux
With
potassium hydroxide;
In
methanol;
|
2.What is the CAS number for 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- ?
The CAS number of 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- is 125-66-6.
More information of 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- 125-66-6 are:
|
CAS?Number |
125-66-6 |
|
Density |
1.27g/cm3 |
|
Boiling Point |
617.4°Cat760mmHg |
|
Flash Point |
341.2°C |
3.What are another words for 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- ?
Synonyms?for?17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- 125-66-6:Atis-13-ene-17,18-dioicacid, 15a-carboxy-13-isopropyl- (8CI);Fumaropimaric acid (7CI); 3H-3,10a-Ethanophenanthrene,17,19-dinoratis-15-ene-4,13,14-tricarboxylic acid deriv.
4.What is the molecular formula of 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-?
The chemical formula of ?17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- is?C24H34 O6 which containing 24 Carbon atoms,34 Hydrogen atoms and 6 Oxygen atoms,and the molecular weight of??17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-?is 418.53.
5.What is 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- (125-66-6) used for?
17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)is a triterpenoid acid derivative of ursolic acid, characterized by its molecular formula C30H48O6 and a molecular weight of 504.7 g/mol. 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)is distinguished by its unique chemical structure, which endows it with potential therapeutic properties, including anti-inflammatory, anti-cancer, and anti-diabetic effects.
Relevant articles related to 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-:
|
Article |
Source |
|
Synthesis and antiviral activity of maleopimaric and quinopimaric acids' derivatives |
Tretyakova, Elena V.,Smirnova, Irina E.,Salimova, Elena V.,Odinokov, Victor N. , p. 6543 - 6550 (2015) |
|
SYNTHESE AB-TRANS-ANELLIERTER DERIVATE DES TRICYCLISCHEN DITERPENS PLEUROMUTILIN DURCH INTRAMOLEKULARE 1,5-HYDRID-VERSCHIEBUNG |
Berner, H.,Schulz, G.,Schneider, H. , p. 1807 - 1811 (2007/10/02) |
6.Buy 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- with the best price .
DATO Chemicals Co., Limited is a quality supplier of 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-. Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on 17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)- 125-66-6.